Globus Medical (GMED) Misses Q1 EPS by 5c, Confirms Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Globus Medical Reports First Quarter 2019 Results
May 2, 2019 4:18 PM EDTAUDUBON, Pa., May 02, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31, 2019.
Worldwide sales were $182.9 million, an increase of 4.9% as reportedFirst quarter net income was $33.2 million, a decrease of 16.0%Diluted earnings per share (EPS) was $0.33 and non-GAAP diluted EPS was $0.36Non-GAAP diluted EPS decreased 13.4% compared to first quarter of 2018Non-GAAP adjusted EBITDA was 31.1% of salesOur first quarter results demonstrate continued strong momentum in... More
